Leslie Michael Shaw - Nanotechnology

Author Information

Leslie Michael Shaw is a distinguished scientist affiliated with the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine, University of Pennsylvania, located at 3400 Civic Center Blvd, Philadelphia, PA 19104, USA. His research primarily focuses on neurodegenerative diseases, particularly Alzheimer's disease, and various biomarkers associated with these conditions.

Research Contributions

Leslie Michael Shaw has made significant contributions to the field of neurodegenerative disease research. In 2021 alone, he has published numerous papers on diverse topics such as the detection of β-amyloid positivity in Alzheimer's Disease, the role of Neurofilament Light Chain in Frontotemporal Lobar Degeneration, and the implications of insulin and IGF signaling in breast cancer therapy. His work also extends to the development and evaluation of nanoparticle-based immunoassays and the identification of prognostic biomarkers for Alzheimer's disease. Additionally, his research includes safety protocols for conducting Alzheimer's biomarker research during the COVID-19 era and the study of mutation carriers in Parkinson's disease.

Aliases

Leslie Michael Shaw is known by various aliases, including but not limited to Les Shaw, Leslie M. Shaw, L. M. Shaw, Leslie Shaw, and L. Shaw.

Publication and Citation Metrics

Citation Count 38,006
H-Index 99
Paper Count 645

Publications:

DOI: 10.1016/j.jbc.2021.101244

Year: 2021

Partnered Content Networks

Relevant Topics